Difficulty: Medium
Average Score: 82%
Practice
A 35-year-old female who has never been pregnant suffers each month from pain, discomfort, and mood depression at the time of menses. She may benefit from the use of this selective inhibitor of the reuptake of serotonin.
Correct answer
D
Rationale
The correct answer is D) Paroxetine. Paroxetine is a selective inhibitor of serotonin reuptake, making it a suitable choice for treating premenstrual symptoms like pain, discomfort, and mood depression in the scenario described. This drug helps increase the levels of serotonin in the brain, which can alleviate the symptoms associated with premenstrual dysphoric disorder (PMDD) in women.
A) Amitriptyline is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of serotonin and norepinephrine. While it can be used for various conditions, it is not the first-line choice for PMDD.
B) Bupropion is an atypical antidepressant that primarily affects the reuptake of dopamine and norepinephrine. It is not typically used to manage symptoms of PMDD.
C) Mirtazapine is another atypical antidepressant that mainly acts by increasing serotonin and norepinephrine levels through different mechanisms than selective serotonin reuptake inhibitors (SSRIs) like paroxetine. It is not commonly indicated for PMDD.
In an educational context, understanding the pharmacological mechanisms of different CNS drugs is crucial for selecting the most appropriate treatment for specific conditions. By knowing how each drug works, healthcare providers can make informed decisions to optimize patient care and outcomes. In this case, the knowledge of paroxetine's mechanism as an SSRI helps in choosing the most effective option for managing the patient's symptoms related to PMDD.
A) Amitriptyline is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of serotonin and norepinephrine. While it can be used for various conditions, it is not the first-line choice for PMDD.
B) Bupropion is an atypical antidepressant that primarily affects the reuptake of dopamine and norepinephrine. It is not typically used to manage symptoms of PMDD.
C) Mirtazapine is another atypical antidepressant that mainly acts by increasing serotonin and norepinephrine levels through different mechanisms than selective serotonin reuptake inhibitors (SSRIs) like paroxetine. It is not commonly indicated for PMDD.
In an educational context, understanding the pharmacological mechanisms of different CNS drugs is crucial for selecting the most appropriate treatment for specific conditions. By knowing how each drug works, healthcare providers can make informed decisions to optimize patient care and outcomes. In this case, the knowledge of paroxetine's mechanism as an SSRI helps in choosing the most effective option for managing the patient's symptoms related to PMDD.